1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This grant may no longer be accepting applications.
The description indicates applications may be closed. Check the funder's website to confirm availability before applying.
Visit funder's website →This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFDA Research Fellowship: Evaluation of Human Sex-biased MicroRNAs in Regulation of Coagulation Proteins is sponsored by U.S. Food and Drug Administration (FDA). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
FDA Research Fellowship: Evaluation of Human Sex-biased MicroRNAs in Regulation of Coagulation Proteins This opportunity is closed. U.S. Food and Drug Administration (FDA) To submit your application, scroll to the bottom of this opportunity and click APPLY.
A complete application consists of: Transcripts – Click here for detailed information about acceptable transcripts A current resume/CV, including academic history, employment history, relevant experiences, and publication list One educational or professional recommendation All documents must be in English or include an official English translation. If you have questions, send an email to ORISE. FDA.
OC. other@orau. org .
Please include the reference code for this opportunity in your email. Connect with ORISE... on the GO!
Download the new ORISE GO mobile app in the Apple App Store or Google Play Store to help you stay engaged, connected, and informed during your ORISE experience and beyond! 5/22/2026 3:00:00 PM Eastern Time Zone *Applications will be reviewed on a rolling-basis.
FDA Office and Location: There are two postdoctoral fellowship opportunities available with Dr. Chava Kimchi-Sarfaty and located at FDA's Hemostasis Branch 1 (HB1), Division of Hemostasis (DH), Office of Plasma Protein Therapeutics (OPPT), Office of Therapeutic Products (OTP), Center for Biologics Evaluation and Research (CBER) in White Oak , Maryland.
Funding for this opportunity will be provided by the Office of Commissioner (OC), Office of Women's Health (OWH).
The Oak Ridge Institute for Science and Education (ORISE) Research Participation Programs at the U.S. Food and Drug Administration are educational and training programs designed to provide students and recent graduates, opportunities to participate in project-specific research and developmental activities at the Office of Women’s Health (OWH).
OWH mission is to address issues of women’s health and coordinate efforts to establish and advance a women’s health agenda for FDA.
Research Project: Under the guidance of the mentor, the participant will investigate sex-biased microRNAs (miRNAs) and their regulatory effects on coagulation proteins, particularly ADAMTS13 and von Willebrand Factor (VWF), to understand sex-dependent differences in bleeding disorders such as thrombotic thrombocytopenic purpura (TTP) and von Willebrand Disease (VWD).
This research aims to improve FDA-regulated product quality, safety, and efficacy for women's health applications and facilitate development of sex-specific therapeutic strategies.
Learning Objectives: During the postdoctoral fellowship, you will have the opportunity to: Develop understanding of sex-biased miRNA regulation in hemostasis and coagulation protein expression Learn to apply in-silico prediction tools and bioinformatics approaches to identify miRNA-target gene interactions Gain experience in molecular biology techniques including cell culture, transfection, qPCR, Western blot, and ELISA Learn to perform luciferase reporter assays for miRNA binding validation Develop skills in characterizing protein expression and functional activity in cellular systems Understand the application of AAV-mediated gene delivery systems for miRNA studies Apply acquired knowledge to support regulatory science and women's health research initiatives Mentor: The mentor for this opportunity is Chava Kimchi-Sarfaty ( chava.
kimchi-sarfaty@fda. hhs. gov ).
If you have questions about the nature of the research, please contact the mentor. Anticipated Appointment Start Date: 2026. Start date is flexible and will depend on a variety of factors.
Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds. Level of Participation: The appointment is full time. Participant Stipend: The participant will receive a monthly stipend commensurate with educational level and experience.
Citizenship Requirements: This opportunity is available to U.S. citizens and Lawful Permanent Residents (LPR) only. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The participant will receive a monthly stipend commensurate with educational level and experience.
Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits. Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA.
OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate the relationship, then the individual is not placed at FDA.
For additional requirements, see FDA Ethics for Nonemployee Scientists . FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency.
This agreement covers such topics as the following: Non-employee nature of the ORISE appointment; Prohibition on ORISE Fellows performing inherently governmental functions; Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship; The fact that research materials and laboratory notebooks are the property of the FDA; ORISE fellow’s obligation to protect and not to further disclose or use non-public information.
The qualified candidate should be currently pursuing or have received a doctoral degree in the one of the relevant fields (e.g. molecular and cell biology, pharmacology and drug discovery/development). Degree must have been received within the past five years, or anticipated to be received by 4/30/2026 . Lab skills in common molecular and cell biology techniques are preferred.
Citizenship: LPR or U.S. Citizen Degree: Doctoral Degree received within the last 60 months or anticipated to be received by 4/30/2026 12:00:00 AM. Life Health and Medical Sciences ( 51 ) I am a U.S. citizen, or I have lived in the United States for at least 36 out of the past 60 months. (36 months do not have to be consecutive.)
I have read the FDA Ethics Requirements. The ORISE GO mobile app helps you stay engaged, connected and informed during your ORISE experience – from application, to offer, through your appointment and even as an ORISE alum! If you need assistance using this site, please send an email to Zintellect@orau.
org . Please rate your experience, and/or leave a comment. How would you rate your overall experience with Zintellect?
You gave a rating of 0 star(s) This box is meant for feedback only. Please direct questions to the program POC or zintellect@orau. org Security/Privacy Statement Close Security/Privacy Statement By continuing to use this system you indicate your awareness of and consent to the following terms and conditions of use.
LOGOUT IMMEDIATELY if you do not agree to the conditions stated in this warning. This system is part of a Federal information system. This system is monitored for security purposes to ensure it remains available to all users and to protect information in the system.
The system employs software programs to monitor network traffic to identify unauthorized activities. By accessing this system, you are expressly consenting to these monitoring activities.
Unauthorized attempts to defeat or circumvent security features; to use the system for other than intended purposes; to deny service to authorized users; to access, obtain, alter, damage, or destroy information; to upload or change information; to otherwise cause system or information damage; or otherwise to interfere with the system or its operation, is prohibited.
Evidence of such acts may be dis-closed to law enforcement authorities and result in prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996, or other applicable laws. This system is for authorized use only. Use of this system constitutes consent to security monitoring and testing.
All activity is logged with your host name and IP address. Users (authorized or unauthorized) have no explicit or implicit expectation of privacy. Any or all uses of this system and all files on this system may be intercepted, monitored, recorded, copied, audited, inspected, and dis-closed to authorized site and law enforcement personnel, as well as authorized officials of other agencies, both domestic and foreign.
By using this system, the user consents to such interception, monitoring, recording, copying, auditing, inspection, and disclosure at the discretion of authorized site or law enforcement personnel. Unauthorized or improper use of this system may result in administrative disciplinary action and civil and criminal penalties. Close Close Security/Privacy Statement You have been inactive on this page for .
You will be logged out after 03:00:00. Close Compatible Browsers Select an icon below to visit the website and download an appropriate browser. Close Close Compatible Browsers For help, please email Zintellect@orau.
org . Question: What is the deadline for submitting an application? Answer: Not all opportunities have application deadlines.
Some opportunities remain open until they are filled. If an opportunity has an application deadline, then it will be listed in the opportunity details or in the opportunity catalog. Question: How do I reset my password?
Answer: If you have forgotten your password or wish to reset your password, use the "Forgot password or username?" tab on the login to reset it. Question: I forgot my username.
How do I retrieve it? Answer: Use the "Forgot password or username?" tab on the login.
You will receive an email containing your username. Question: What do I need to submit an application? Answer: Typically, applicants are required to submit a resume or CV, an official copy of their transcripts or academic record, and a minimum of two references at the time they apply.
Additional requirements such as a writing sample, thesis or dissertation, etc. may be required. Review the opportunity details for additional information about the requirements for applying for an opportunity. Question: Where do I upload my transcripts?
Answer: If required, you will be asked to upload your transcript as a part of the application process. Question: Where do I submit a writing sample? Answer: If required, you will be asked to upload a writing sample as part of the application process.
Question: Can a family member serve as a reference? Answer: No; family members may not serve as references. References must be able to speak to your educational and/or professional experience.
At least one academic reference is preferred. Forgot password or username? Invalid or expired username or password.
You can try again or reset your password using the 'Forgot password or username?' tab above. Select an option below and enter the email address associated with your Zintellect account.
You will receive an email with additional information for your account. If you need additional assistance, please contact Zintellect Support . Invalid email.
Please try again. I forgot / need to reset my password Please select your appropriate user type Did the opportunity match? Close Did the opportunity match?
Our Zintellect A. I. is constantly learning how to Match you to our opportunities!
So, we want to know when we get it right or when we get it wrong. This will help us make our better! Plus, as a potential applicant to one of our many opportunities across the country, we value you and want to help you on your career path!
According to the current listing, eligibility includes: Postdoctoral researchers with a background in molecular biology and biochemistry. Confirm the full requirements in the official notice before applying.
FDA Research Fellowship: Evaluation of Human Sex-biased MicroRNAs in Regulation of Coagulation Proteins is funded by U.S. Food and Drug Administration (FDA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The AFID Infrastructure Grant program closes October 30, 2026. Awards top out at $50,000, they are reimbursable, and only a political subdivision can apply. The August round put $507,000 into 14 projects at an average of about $36,000.
Read articleThe Cold Chain Grants for Emergency Food Assistance Program closes October 1, 2026, funding cold storage equipment at up to $200,000 per project with a 10% cash match. But USDA is not awarding to food banks — it is awarding to nonprofit intermediaries who will run competitive subaward programs. Two audiences, two entirely different jobs, and one of them has 43 days.
Read articleMissouri's Department of Agriculture has reopened its Urban Agriculture Cost-Share Grant — reimbursing 75% of project costs up to $10,000, with applications due September 15, 2026. A companion Food Insecure Cost-Share Grant closes August 26. Here is how these small, fast state grants work, who qualifies under the Census 'urban area' definition, and how to layer them with the federal USDA Urban Agriculture and Innovative Production program for a durable urban-farming funding strategy.
Read article